Methods of treating hematological proliferative disorders by targeting EphA3 expressed on aberrant vasculature in bone marrow
US9109032B2 · kind B2 · utility
1Cited by
0References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 10, 2012 |
| Grant date | Aug 18, 2015 |
| Priority date | — |
| Expiry date | Aug 10, 2032 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/52
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The invention provides diagnostic and therapeutic methods for the treatment of hematological proliferative disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.